lifestyle.ukuncut.org.uk
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Mabwell (Shanghai) Bioscience Co., Ltd.
Annualized Severe COPD Exacerbation Rate Reduced by Over 40%: Mabwell Announces Phase IIa Results for Innovative Anti-ST2 Antibody 9MW1911
December 1, 2025
Mabwell Announces First-Patient Dosing for Novel CDH17-Targeting ADC 7MW4911
November 25, 2025
←
Previous Page
1
2